Family Care Hospitals Ltd (516110)
சுருக்கம்
The board meets on 13 Nov 2026 to consider the Q2 FY27 results.
நிகழ்வுகள்
- அடுத்த முடிவுகள்
- 13 நவ. 2026 (Q2 FY27)
- சமீபத்திய முடிவுகள்
- Q1 FY27, தாக்கல் செய்யப்பட்டது 1 ஆக. 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 10 நவ. 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
📅 அடுத்த நிதி முடிவுகள்: 13 நவ. 2026 (இயக்குநர் குழுக் கூட்டம்)Family Care Hospitals Ltd-இன் இயக்குநர் குழுக் கூட்டம் 13 நவ. 2026 அன்று நடைபெறுகிறது; அதில் அதன் Q2 FY27 முடிவுகள் பரிசீலிக்கப்படும் (ஜூலை-செப்டம்பர் 2026).
In its latest reported quarter, Q1 FY27, Family Care's revenue was ₹0.1 Cr (+150.0% year on year, -16.7% on the previous quarter), and net profit ₹-0.4 Cr (a smaller loss than a year earlier); the operating margin was -342.4%.
| Q1 FY27 (₹ கோடி) | மதிப்பு | YoY Q1 FY26-உடன் | QoQ |
|---|---|---|---|
| வருவாய் | ₹0.1 | +150.0% | -16.7% |
| செயல்பாட்டு லாபம் | ₹-0.2 | நஷ்டம் குறைந்தது | நஷ்டமாக |
| நிகர லாபம் | ₹-0.4 | நஷ்டம் குறைந்தது | நஷ்டம் குறைந்தது |
| EPS (₹) | -0.08 | நஷ்டம் குறைந்தது | நஷ்டம் குறைந்தது |
| செயல்பாட்டு லாப வரம்பு | -342.4% | — | — |
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Family Care Hospitals has scheduled a meeting of its Board of Directors for November 13, 2026. The board will consider and approve the standalone un-audited financial results along with the Limited Review Report for the quarter ended September 30, 2026. The company's trading window remains closed from October 1, 2026, until 48 hours following the declaration of results. The company reported TTM net losses of Rs -8 Cr on negligible revenue.
- Board meeting scheduled for Friday, November 13, 2026
- Agenda includes approval of Standalone Un-Audited Financial Results for quarter ended September 30, 2026
- Trading window closed from October 1, 2026, until 48 hours post result declaration
Non-promoter shareholder Dr. Sowmya Deshpande disclosed the sale of 5,49,989 equity shares (1.02% of voting capital) in Family Care Hospitals Ltd through open market transactions between August 15, 2026, and September 28, 2026. Following this transaction, her holding declined from 15,50,258 shares (2.87%) to 10,00,269 shares (1.85%). The company currently operates with a market cap of Rs 11 Cr, having reported Rs 0 Cr TTM revenue and ongoing operational losses.
- Sold 5,49,989 equity shares representing 1.02% of total share capital
- Pre-transaction holding stood at 15,50,258 shares (2.87%)
- Post-transaction holding decreased to 10,00,269 shares (1.85%)
- Sales occurred via open market between August 15, 2026, and September 28, 2026
- Total voting capital remained unchanged at 5,40,14,774 equity shares
Family Care Hospitals Limited has scheduled a meeting of its Board of Directors on September 2, 2026, to finalize arrangements for its 32nd Annual General Meeting (AGM) and approve the draft Annual Report for FY 2025-26. The board will also consider fixing a Record Date for a potential final dividend for FY 2025-26 (if declared) and appoint scrutinizers and RTA agencies for remote e-voting. This is a standard corporate compliance filing for the company, which reported FY26 revenue of Rs 0.21 Cr and a net loss of Rs 8.69 Cr.
- Board meeting scheduled for September 2, 2026, via video conferencing/audio-visual means
- Board to approve the Notice of the 32nd AGM and the draft Annual Report for FY 2025-26
- Agenda includes fixing the Record Date for determining eligibility for any FY26 Final Dividend
- M/s. Ajay Kumar & Co. proposed for appointment as Scrutinizer for the AGM e-voting facility
Non-promoter shareholder Dr. Sowmya Deshpande disclosed the sale of 7,52,871 equity shares (1.34% of total share capital) of Family Care Hospitals Ltd via open market transactions. The disposal took place between August 12, 2026, and August 14, 2026. Following this transaction, the shareholder's stake decreased from 23,03,129 shares (4.26%) to 15,50,258 shares (2.82%).
- Sold 7,52,871 equity shares representing 1.34% of total share capital via open market
- Disposal executed across the period from August 12, 2026, to August 14, 2026
- Pre-sale holding reduced from 23,03,129 shares (4.26%) down to 15,50,258 shares (2.82%)
- Total diluted and voting share capital remains unchanged at 5,40,14,774 shares (Rs 54.01 Cr)
Non-promoter shareholder Dr. Sowmya Deshpande sold 9,56,007 equity shares (representing 1.77% of total voting capital) of Family Care Hospitals Ltd via open market transactions between August 7, 2026, and August 11, 2026. Prior to the disposal, Dr. Deshpande held 32,59,136 shares (6.03% stake). Following the sale, the holding stands reduced to 23,03,129 shares (4.26%), falling below the 5% substantial shareholding threshold. The company's total equity base remains unchanged at 5,40,14,774 equity shares.
- Sold 9,56,007 equity shares (1.77% stake) via open market between August 7, 2026, and August 11, 2026
- Pre-sale holding reduced from 32,59,136 shares (6.03%) to 23,03,129 shares (4.26%)
- Total voting capital remains at 5,40,14,774 equity shares (Rs 54.01 Cr face value at Rs 10 each)
- Seller does not belong to the promoter or promoter group
Dr. Sowmya Deshpande, a non-promoter shareholder, sold 9,56,007 shares representing a 1.77% stake in Family Care Hospitals between August 7 and August 11, 2026. This transaction reduced her total holding from 6.03% to 4.26%. The sale was conducted through the open market. Given the company's micro-cap status (Rs 12 Cr) and negligible revenue (Rs 0.21 Cr in FY26), such exits by significant shareholders are notable.
- Sold 9,56,007 equity shares via open market transactions.
- Shareholding reduced from 6.03% (32,59,136 shares) to 4.26% (23,03,129 shares).
- Disposal occurred over a five-day window from August 7, 2026, to August 11, 2026.
- The seller is classified as a non-promoter individual.
- Total equity share capital of the company stands at 5,40,14,774 shares.
Family Care Hospitals reported a net loss of ₹42.37 lakhs for Q1 FY27 on a marginal revenue of ₹5.00 lakhs. The company appointed Mr. Ashdullah Khan as Company Secretary and Compliance Officer effective July 31, 2026. A critical concern is the auditor's emphasis on ₹38.03 crore worth of 'Discount Coupon Vouchers' held in inventory, which is significantly higher than the company's total market cap of ₹15 crore. These vouchers remain unutilized due to the closure of main hospital operations, and their realizable value is uncertain pending shareholder approval for a related-party transfer.
- Net loss for the quarter ended June 30, 2026, stood at ₹42.37 lakhs compared to a loss of ₹69.51 lakhs YoY.
- Revenue from operations remained minimal at ₹5.00 lakhs for the quarter.
- Auditors flagged ₹38.03 crore in inventory (Discount Coupon Vouchers) which is ~253% of the company's market capitalization.
- Main hospital operations remain closed, leading to the non-utilization of the recorded inventory.
- Mr. Ashdullah Khan appointed as Company Secretary & Compliance Officer effective July 31, 2026.
Family Care Hospitals Ltd has postponed its board meeting, originally scheduled for July 24, 2026, to July 31, 2026. The delay is due to the non-finalization of unaudited financial results for the quarter ended June 30, 2026. This comes at a time when the company is struggling with negligible TTM revenue and a significant FY25 net loss of Rs 44.15 Cr. The trading window for insiders remains closed since July 1, 2026.
- Board meeting postponed from July 24, 2026, to July 31, 2026
- Reason for delay is the non-finalization of results for the quarter ended June 30, 2026
- Trading window has been closed since July 01, 2026
- Company reported a net loss of Rs 44.15 Cr in FY25
- Market capitalization stands at a micro-cap level of Rs 14 Cr
Family Care Hospitals Ltd has scheduled a board meeting for July 24, 2026, to consider and approve the standalone unaudited financial results for the quarter ended June 30, 2026. The company is currently a micro-cap with a market capitalization of Rs 15 Cr and has reported negligible TTM revenue of Rs 0 Cr. With a TTM PAT loss of Rs -9 Cr and a negative OPM of -1609.5%, the upcoming results are critical for assessing operational viability. The trading window for designated persons has been closed since July 1, 2026.
- Board meeting scheduled for July 24, 2026, to approve Q1 FY27 results
- Trading window closed from July 1, 2026, until 48 hours after result declaration
- Company reports a TTM PAT loss of Rs -9 Cr against a market cap of Rs 15 Cr
- TTM revenue stands at Rs 0 Cr, indicating minimal operational activity
- Promoter holding remains low at 18.54% as of March 2026
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
